| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.VACCINE.2011.12.056 |
| P698 | PubMed publication ID | 22197963 |
| P2093 | author name string | John R Barr | |
| James L Pirkle | |||
| Tracie L Williams | |||
| P2860 | cites work | Sequencing of oxidized methionine-containing peptides for protein identification | Q73207872 |
| Database resources of the National Center for Biotechnology Information | Q29614751 | ||
| Influenza pandemic planning. | Q30332720 | ||
| Quantification of influenza virus hemagglutinins in complex mixtures using isotope dilution tandem mass spectrometry. | Q30369076 | ||
| Sample preparation for peptide mapping--A pharmaceutical quality-control perspective | Q30432451 | ||
| Oxidative post-translational modification of tryptophan residues in cardiac mitochondrial proteins | Q30771213 | ||
| Enzyme-friendly, mass spectrometry-compatible surfactant for in-solution enzymatic digestion of proteins | Q33194375 | ||
| LC/MS characterization of undesired products formed during iodoacetamide derivatization of sulfhydryl groups of peptides | Q33268374 | ||
| Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins | Q34350453 | ||
| Evolution of seed allergen quantification--from antibodies to mass spectrometry. | Q37772255 | ||
| An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: Application for potency determinations of inactivated whole virus and subunit vaccines | Q41295537 | ||
| Inactivation of DNA by beta-propiolactone | Q41300885 | ||
| Targeted N-linked glycosylation analysis of H5N1 influenza hemagglutinin by selective sample preparation and liquid chromatography/tandem mass spectrometry | Q44245308 | ||
| Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection | Q44631148 | ||
| Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans | Q44817736 | ||
| Optimization of digestion parameters for protein quantification | Q45283936 | ||
| Inhibition of virus-induced hemolysis with monoclonal antibodies to different antigenic areas on the hemagglutinin molecule of A/seal/Massachusetts/1/80 (H7N7) influenza virus | Q45804747 | ||
| Spin-labeling of influenza virus hemagglutinin permits analysis of the conformational change at low pH and its inhibition by antibody | Q45836300 | ||
| Amino acid analysis of peptides using isobaric-tagged isotope dilution LC-MS/MS. | Q48014028 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2475-2482 | |
| P577 | publication date | 2011-12-22 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Simultaneous quantification of hemagglutinin and neuraminidase of influenza virus using isotope dilution mass spectrometry | |
| P478 | volume | 30 |
| Q35690712 | A Proteomic Characterization of Bordetella pertussis Clinical Isolates Associated with a California State Pertussis Outbreak. |
| Q30365391 | A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines. |
| Q61445511 | A neuraminidase potency assay for quantitative assessment of neuraminidase in influenza vaccines |
| Q34274867 | Analytical reactivity of 13 commercially available rapid influenza diagnostic tests with H3N2v and recently circulating influenza viruses |
| Q58562964 | Assessment of potency of inactivated Newcastle disease oil-adjuvanted vaccines using hemagglutination test and blocking ELISA |
| Q100675925 | Comprehensive Analysis of the Glycan Complement of SARS-CoV-2 Spike Proteins Using Signature Ions-Triggered Electron-Transfer/Higher-Energy Collisional Dissociation (EThcD) Mass Spectrometry |
| Q30364635 | Considerations for the rapid deployment of vaccines against H7N9 influenza. |
| Q30377883 | Critical review of current and emerging quantification methods for the development of influenza vaccine candidates. |
| Q34971083 | Determination of neuraminidase kinetic constants using whole influenza virus preparations and correction for spectroscopic interference by a fluorogenic substrate |
| Q92229180 | Hemagglutinin Quantitative ELISA-based Potency Assay for Trivalent Seasonal Influenza Vaccine Using Group-Specific Universal Monoclonal Antibodies |
| Q28396333 | Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs |
| Q40095655 | Immunocapture isotope dilution mass spectrometry in response to a pandemic influenza threat |
| Q90571133 | Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies |
| Q30249879 | Influenza virus neuraminidase (NA): a target for antivirals and vaccines |
| Q41898517 | Label-free quantitative mass spectrometry for analysis of protein antigens in a meningococcal group B outer membrane vesicle vaccine |
| Q34365214 | Mass spectrometric approaches to study enveloped viruses: new possibilities for structural biology and prophylactic medicine |
| Q91991047 | Measurement of surface protein antigens, PorA and PorB, in Bexsero vaccine using quantitative mass spectrometry |
| Q57094018 | Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness |
| Q38202170 | Physicochemical and functional characterization of vaccine antigens and adjuvants |
| Q42231387 | Quantification by LC-MS(E) of outer membrane vesicle proteins of the Bexsero® vaccine |
| Q40334782 | Quantification of Influenza Neuraminidase Activity by Ultra-High Performance Liquid Chromatography and Isotope Dilution Mass Spectrometry |
| Q30360870 | Quantification of viral proteins of the avian H7 subtype of influenza virus: an isotope dilution mass spectrometry method applicable for producing more rapid vaccines in the case of an influenza pandemic |
| Q39028835 | Recombinant viral-vectored vaccines for the control of avian influenza in poultry |
| Q57093521 | Reference antigen-free and antibody-free LTD-IDMS assay for influenza H7N9 vaccine in vitro potency determination |
| Q30360024 | Stability of neuraminidase in inactivated influenza vaccines. |
| Q47550493 | Standardisation of inactivated influenza vaccines-Learning from history |
| Q88935087 | The expanding role of mass spectrometry in the field of vaccine development |
| Q35351086 | Titer on chip: new analytical tool for influenza vaccine potency determination |
| Q40335210 | Ultrasensitive Fluorogenic Reagents for Neuraminidase Titration |
| Q91592191 | Universal monoclonal antibody-based influenza hemagglutinin quantitative enzyme-linked immunosorbent assay |
| Q46527392 | VaxArray assessment of influenza split vaccine potency and stability |
| Q59349196 | VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines |
Search more.